2010 Conference
13th GERPAC Conference
8th European GERPAC
Sterile drugs preparation
8th European GERPAC
Sterile drugs preparation
October 6, 7 & 8 - Hyères - France
Microbiology controls in sterile compounding
Viability of microorganisms in cytotoxic and antiviral drug solutions
Irene Krämer
Department of Pharmacy, University Medical Center,
Johannes Gutenberg-University, Langenbeckstraße 1,
55131 Mainz, Germany Medicines preparation and manufacturing in the British National Health Service S. Langford Huddersfield Royal Infirmery, Huddersfield, UK Microbiological environmental monitoring of Pharmaceutical Clean Rooms P. Simmons Calderdale & Huddersfield NHS Foundation Trust, UK New microbiological methods for sterile compounding: Are there applications to hospital pharmacies? S. Guyomard S. Guyomard - ACM Pharma, France
Johannes Gutenberg-University, Langenbeckstraße 1,
55131 Mainz, Germany Medicines preparation and manufacturing in the British National Health Service S. Langford Huddersfield Royal Infirmery, Huddersfield, UK Microbiological environmental monitoring of Pharmaceutical Clean Rooms P. Simmons Calderdale & Huddersfield NHS Foundation Trust, UK New microbiological methods for sterile compounding: Are there applications to hospital pharmacies? S. Guyomard S. Guyomard - ACM Pharma, France
Imaging Tool for Quality Control
Video recording for quality control of cytotoxic preparations
B. Le Franc, B. Dalifard, E. Griesemann, J.P. Cante
Pharmacie URC, Centre Hospitalier, La Rochelle, France
Innovations in Chemotherapy Preparation Safety
Use of Telepharmacy and Barcode Technology in the IV Admixture Area B. O’Neal The University of Kansas Hospital, USA Asynchronous validation and documentation of the compounding of sterile preparations using digital cameras D. Lebel Département de Pharmacie, CHU Sainte-Justine, Montréal, Québec (514) 345-4931 poste 5575
Use of Telepharmacy and Barcode Technology in the IV Admixture Area B. O’Neal The University of Kansas Hospital, USA Asynchronous validation and documentation of the compounding of sterile preparations using digital cameras D. Lebel Département de Pharmacie, CHU Sainte-Justine, Montréal, Québec (514) 345-4931 poste 5575
Cytotoxic Oral Therapy
Oral cytotoxics: iatrogenic risks?
L. Vincent 1, F. Giraudier2, P. Le Rat1, D. Antal1, N. Boullanger1, V. Grangeon-Vincent3, P. Hild2
1 Service d’Oncologie et Hématologie, Centre Hospitalier, Roanne, France lionel.vincent@ch-roanne.fr
2 Service Pharmacie, Unité de reconstitution des cytotoxiques, Centre Hospitalier, Roanne
3 Service de Pneumologie, Centre Hospitalier, Roanne, France Compliance example- Early discontinuation of tamoxifen T.I. Barron, R. Connolly, K. Bennett, J. Feely, M.J. Kennedy Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Ireland
Tolerance of oral Therapy F. Lokiec Centre René Huguenin, Saint-Cloud, France Therapeutic education
How to prepare patients to play an active part in their treatment F. Lemare Institut Gustave Roussy, Service Pharmacie, Villejuif, France
Faculté des sciences pharmaceutiques de l’université Paris Descartes, Paris, France Oral, Off-patent, Oncology drugs for Kids (O3K Project) A. Paci Institut Gustave Roussy, Villejuif, France
2 Service Pharmacie, Unité de reconstitution des cytotoxiques, Centre Hospitalier, Roanne
3 Service de Pneumologie, Centre Hospitalier, Roanne, France Compliance example- Early discontinuation of tamoxifen T.I. Barron, R. Connolly, K. Bennett, J. Feely, M.J. Kennedy Department of Pharmacology and Therapeutics, Trinity Centre for Health Sciences, St James’s Hospital, Dublin 8, Ireland
Tolerance of oral Therapy F. Lokiec Centre René Huguenin, Saint-Cloud, France Therapeutic education
How to prepare patients to play an active part in their treatment F. Lemare Institut Gustave Roussy, Service Pharmacie, Villejuif, France
Faculté des sciences pharmaceutiques de l’université Paris Descartes, Paris, France Oral, Off-patent, Oncology drugs for Kids (O3K Project) A. Paci Institut Gustave Roussy, Villejuif, France
Ophtlamic therapy
Formulation of ophthalmologic forms in hospital
D. Brossard
Université Paris Descartes, Faculté de Pharmacie, UPGCI, INSERM U1022, CNRS UMR 8151, Paris, France
Stability of ophthalmic preparations
Valérie Sautou
Pharmacie CHU G. Montpied, Rue Montalembert, 63003 Clermont-Ferrand
EA 4676 C-Biosenss, UFR Pharmacie, Université d’Auvergne, Place Henri Dunant, 63001 Clermont-Ferrand Toxicity of ocular formulations P. Rat Laboratoire de Toxicologie, Faculté de Pharmacie (Université Paris Descartes), Paris, France
EA 4676 C-Biosenss, UFR Pharmacie, Université d’Auvergne, Place Henri Dunant, 63001 Clermont-Ferrand Toxicity of ocular formulations P. Rat Laboratoire de Toxicologie, Faculté de Pharmacie (Université Paris Descartes), Paris, France
Short oral communications
Implementation of dose standardisation
F. Daoudi1, C. Trento1, C .Giard1, A. Hurgon1, J. Pauly1, A. Pelloquin1, P. Cottu2, L. Escalup1
1 Pharmacy, Curie Institute, Paris, France2 HDJ, Day hospital, Curie Institute, Paris, France
Short oral scientific communication 2
M. Saliège 1, S. Roos2, A. Grand3
1 Pharmacie, hôpital Gabriel-Montpied, CHU Clermont-Ferrand, France
2 Pharmacie, hôpital André Grégoire, CHI Montreuil, Montreuil, France
3 Pharmacie, hôpital Rangueil, CHU Toulouse, Toulouse, France Modelling of the cost of preparation of injectable cytotoxics: application to 2 institutions T. Boulet 1, S. Drouot 2, J.L. Pons 2, J.M. Descoutures 2, M. Sinègre 1 1 Pharmacie, CHU Beaujon, Paris, France
2 Pharmacie, Centre Hospitalier, Argenteuil, France
Determination of a pertinent activity indicator for preparation in a hospital pharmacy S. Maier1, C. Malbranche2, D. Jacob3, I. Roland4 1 Pharmacie CHUV, Lausanne, Suisse
2 Pôle pharmaceutique, CHU, Dijon, France
3 Pharmacie, Centre Hospitalier, Nevers, France
4 Pharmacie, CHU, Liège, Belgique Economic impact of error prevention in the production of injectable chemotherapies H. Mockly-Postal, S. Perrin, V. Nerich, C. Fleck, A. Fousseret, A. Bossu, X. Fierobe, B. Maître, C. Fagnoni Legat, S. Limat Pôle Pharmaceutique, CHU, Besançon, France Implementing a point-of-care activated system for amoxiclav-1g infusion in nursing wards: obstacles and key factors for success M. Courtois1, O. Hamdan2, N. Brousmiche2, J. Adant1, B. Lemaitre2, J. Douchamps1 1 Pharmacy department, CHU de Charleroi (CHUC), André Vésale Hospital, Montigny-Le-Tilleul, Belgium
2 Centre de Santé des Fagnes Hospital (CSF), Chimay, Belgium RAMAN spectrum: the first step towards a simple, sample-free, non-destructive method for the verification of cytotoxic preparations? B. Barin, N. Fayad, S. Rochard, P. Baumgartner Service Pharmacie, Centre René Gauducheau, Nantes, France New applicable breakthrough of Raman spectroscopy to the verification of the analytical quality of injectable solutions of anthracyclines A. Amin , A. Moriceau, B. Cassard, R. Clément, P. Bourget Service de Pharmacie Clinique, Hôpital Necker - Enfants Malades, Paris, France Sterilisation of a new generic specialty in an isolator: matching routine and emergency procedures M. Rossignol, F. Giraudier, P. Hild, M. Lefebvre, F. Cabrera, C. Niepceron Pharmacie, Centre Hospitalier, Roanne, France Permeation of the sterilising agent in bags: a simplified routine evaluation method S. Edet, R. Vazquez, M.N. Guerrault-Moro, D. Brossard, S. Crauste-Manciet Centre Hospitalier Poissy-Saint Germain en Laye, Service Pharmacie, Saint Germain en Laye, France
Preliminary analysis for the validation of cross contamination M. Zarid, R. Vazquez, M.N. Guerrault-Moro, D. Brossard, S. Crauste-Manciet Centre Hospitalier Poissy-Saint Germain en Laye , Service Pharmacie, Saint Germain en Laye, France Measurement of chemical cross contamination in the preparation of injectable cytotoxics J. Ramseyer , F. Sadeghipour, P. Bonnabry Pharmacie des Hôpitaux Universitaires de Genève, Section des sciences pharmaceutiques, Université de Genève, Université de Lausanne, Genève, Suisse Optimisation of the production processes of cytotoxics and chemical decontamination P.A. Jolivot1, T. Legrand2, A. Rieutord1, D. Pradeau2, E. Caudron 2, S. Foucher1 1 Pharmacie, Hôpital Antoine Béclère, Clamart, France
2 Laboratoire de Développement Analytique, Agence Générale des Equipements et Produits de Santé, Paris, France Chemotherapy at home: Implementation of a temperature traceability system during transport E. Penet, A. Cournède, A-L. Lepetit, A. Lagarde CHU Dupuytren, Service Pharmacie, Limoges, France
Safety principle in the preparation of cefuroxime for intracamerular injection S. Roche , K. Civiletti, O. Brocque, N. Mérité Service Pharmacie, Centre Hospitalier du Pays d’Aix, Aix en Provence, France
2 Pharmacie, hôpital André Grégoire, CHI Montreuil, Montreuil, France
3 Pharmacie, hôpital Rangueil, CHU Toulouse, Toulouse, France Modelling of the cost of preparation of injectable cytotoxics: application to 2 institutions T. Boulet 1, S. Drouot 2, J.L. Pons 2, J.M. Descoutures 2, M. Sinègre 1 1 Pharmacie, CHU Beaujon, Paris, France
2 Pharmacie, Centre Hospitalier, Argenteuil, France
Determination of a pertinent activity indicator for preparation in a hospital pharmacy S. Maier1, C. Malbranche2, D. Jacob3, I. Roland4 1 Pharmacie CHUV, Lausanne, Suisse
2 Pôle pharmaceutique, CHU, Dijon, France
3 Pharmacie, Centre Hospitalier, Nevers, France
4 Pharmacie, CHU, Liège, Belgique Economic impact of error prevention in the production of injectable chemotherapies H. Mockly-Postal, S. Perrin, V. Nerich, C. Fleck, A. Fousseret, A. Bossu, X. Fierobe, B. Maître, C. Fagnoni Legat, S. Limat Pôle Pharmaceutique, CHU, Besançon, France Implementing a point-of-care activated system for amoxiclav-1g infusion in nursing wards: obstacles and key factors for success M. Courtois1, O. Hamdan2, N. Brousmiche2, J. Adant1, B. Lemaitre2, J. Douchamps1 1 Pharmacy department, CHU de Charleroi (CHUC), André Vésale Hospital, Montigny-Le-Tilleul, Belgium
2 Centre de Santé des Fagnes Hospital (CSF), Chimay, Belgium RAMAN spectrum: the first step towards a simple, sample-free, non-destructive method for the verification of cytotoxic preparations? B. Barin, N. Fayad, S. Rochard, P. Baumgartner Service Pharmacie, Centre René Gauducheau, Nantes, France New applicable breakthrough of Raman spectroscopy to the verification of the analytical quality of injectable solutions of anthracyclines A. Amin , A. Moriceau, B. Cassard, R. Clément, P. Bourget Service de Pharmacie Clinique, Hôpital Necker - Enfants Malades, Paris, France Sterilisation of a new generic specialty in an isolator: matching routine and emergency procedures M. Rossignol, F. Giraudier, P. Hild, M. Lefebvre, F. Cabrera, C. Niepceron Pharmacie, Centre Hospitalier, Roanne, France Permeation of the sterilising agent in bags: a simplified routine evaluation method S. Edet, R. Vazquez, M.N. Guerrault-Moro, D. Brossard, S. Crauste-Manciet Centre Hospitalier Poissy-Saint Germain en Laye, Service Pharmacie, Saint Germain en Laye, France
Preliminary analysis for the validation of cross contamination M. Zarid, R. Vazquez, M.N. Guerrault-Moro, D. Brossard, S. Crauste-Manciet Centre Hospitalier Poissy-Saint Germain en Laye , Service Pharmacie, Saint Germain en Laye, France Measurement of chemical cross contamination in the preparation of injectable cytotoxics J. Ramseyer , F. Sadeghipour, P. Bonnabry Pharmacie des Hôpitaux Universitaires de Genève, Section des sciences pharmaceutiques, Université de Genève, Université de Lausanne, Genève, Suisse Optimisation of the production processes of cytotoxics and chemical decontamination P.A. Jolivot1, T. Legrand2, A. Rieutord1, D. Pradeau2, E. Caudron 2, S. Foucher1 1 Pharmacie, Hôpital Antoine Béclère, Clamart, France
2 Laboratoire de Développement Analytique, Agence Générale des Equipements et Produits de Santé, Paris, France Chemotherapy at home: Implementation of a temperature traceability system during transport E. Penet, A. Cournède, A-L. Lepetit, A. Lagarde CHU Dupuytren, Service Pharmacie, Limoges, France
Safety principle in the preparation of cefuroxime for intracamerular injection S. Roche , K. Civiletti, O. Brocque, N. Mérité Service Pharmacie, Centre Hospitalier du Pays d’Aix, Aix en Provence, France
Workshops
Workshop 1
Main issues on drug stability data - debate with industry Workshop 2
Audit and Self evaluation of cytotoxic preparation unit - check your unit Workshop 3
What are information resources for sterile preparation? Workshop 4
Methods for determination of the needs for personnel for preparation of cytotoxic drugs
Main issues on drug stability data - debate with industry Workshop 2
Audit and Self evaluation of cytotoxic preparation unit - check your unit Workshop 3
What are information resources for sterile preparation? Workshop 4
Methods for determination of the needs for personnel for preparation of cytotoxic drugs